Cellular and/or tissue-based products (CTPs) for skin wounds sit at the intersection of regulations and clinical practice—and the CY 2026 Medicare Physician Fee Schedule (MPFS) final rule makes it essential for physicians and other qualified healthcare professionals (QHPs) to align their clinical decision making with the new payment rule.

In this focused session, reimbursement expert Kathleen Schaum explains how physicians and QHPs should review their formulary of CTPs and make any additions and/or deletions needed to clinically and financially succeed under the CY 2026 MPFS payment changes. Dr. Alton Johnson will follow with real-world diabetic foot ulcer (DFU) cases featuring TheraSkin® and DermACELL® Porous, highlighting clinical decision points, sequencing, and documenting to support medical necessity.

Key takeaways from the live session:

• CY 2026 MPFS updates that impact billing for CTP services in DFU care
• At the bedside: DFU case walk-throughs using CTPs—product selection, sequencing, and follow-up
• Documentation elements to support medical necessity for CTPs
• Technology fit: Tips for optimizing CTP selection and application in complex DFU cases

Our Learning Live expert speakers:

Kathleen D. Schaum, MS

Founder & President, Kathleen D. Schaum & Associates
 

 

Alton R. Johnson Jr. DPM, FACPM, FASPS, FFPM RCPS (Glasg.), CWSP

Assistant Professor of Orthopaedic Surgery, University of Michigan Medical School

 

---

This learning live is proudly sponsored by:

WCT USA Learning Lives provide real-world clinical insights delivered from real wound care experts.